SANICHI
0133
HPI
03060
TALAMT
2259
MICROLN
0126
GPACKET
0082
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 30.47%448.51M | 49.10%455.84M | 119.82%247.12M | 13.09%1.11B | 57.93%351.08M | 1.60%343.76M | 16.07%305.73M | -29.80%112.42M | 47.39%984.18M | 11.06%222.3M |
Cost of revenue | 26.39%239.63M | 46.82%232.31M | 58.26%162M | -2.19%639.11M | 21.56%188.92M | -10.48%189.59M | -6.03%158.23M | -13.15%102.36M | 11.43%653.42M | -24.04%155.41M |
Gross profit | 35.49%208.88M | 51.54%223.53M | 746.19%85.12M | 43.27%473.88M | 142.43%162.15M | 21.81%154.17M | 55.22%147.5M | -76.21%10.06M | 306.60%330.76M | 1,603.75%66.89M |
Operating expense | 22.81%37.38M | 12.93%32.06M | 19.27%29.94M | 20.79%148.06M | 51.49%64.13M | 4.74%30.43M | 10.30%28.39M | -1.36%25.11M | 17.07%122.58M | 41.94%42.33M |
Selling and administrative expenses | 22.69%37.38M | 12.49%32.06M | 19.22%29.94M | 16.14%142.88M | 38.89%58.8M | 4.70%30.46M | 9.90%28.5M | -2.13%25.12M | 15.60%123.03M | 34.22%42.33M |
-General and administrative expense | 22.69%37.38M | 12.49%32.06M | 19.22%29.94M | 16.14%142.88M | 38.89%58.8M | 4.70%30.46M | 9.90%28.5M | -2.13%25.12M | 15.60%123.03M | 34.22%42.33M |
Other operating expenses | ---- | ---- | ---- | --5.5M | ---- | ---- | ---- | ---- | ---- | ---- |
Total other operating income | --0 | --0 | --0 | -29.02%318K | 16,500.00%166K | -23.08%30K | -42.93%113K | -95.71%9K | -73.91%448K | -99.94%1K |
Operating profit | 38.61%171.5M | 60.74%191.46M | 466.65%55.17M | 56.51%325.82M | 299.21%98.03M | 26.90%123.74M | 71.90%119.11M | -189.42%-15.05M | 991.26%208.18M | 171.65%24.56M |
Net non-operating interest income (expenses) | 144.32%1.51M | 116.04%763K | 108.74%402K | 3.55%-18.57M | -9.41%-5.81M | 35.20%-3.4M | 15.96%-4.76M | -51.62%-4.6M | 28.32%-19.25M | 6.98%-5.31M |
Non-operating interest income | -4.00%3.79M | -1.40%3.44M | 26.42%3.47M | 73.40%13.47M | 48.01%3.28M | 110.55%3.95M | 88.45%3.49M | 50.69%2.74M | -4.43%7.77M | 26.85%2.22M |
Non-operating interest expense | -68.89%2.29M | -67.51%2.68M | -58.24%3.07M | 108.95%5.65M | -3.03%-17.3M | 3.20%7.35M | 9.80%8.25M | 51.27%7.34M | -1.10%2.7M | 32.29%-16.79M |
Total other finance cost | ---- | ---- | ---- | 8.52%26.39M | ---- | ---- | ---- | ---- | -24.61%24.32M | ---- |
Net investment income | 4,966.28%49.93M | 104.70%878K | -63,311.76%-10.78M | -9.03%-12.15M | 108.73%7.58M | 90.62%-1.03M | -297.85%-18.68M | -101.97%-17K | -223.53%-11.14M | 400.69%3.63M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -25.38%97K | -33.83%1.24M | 143K | 115.06%42.3M | 454.44%40.29M | -98.23%130K | 30.74%1.88M | 0 | 105.48%19.67M | 102.19%7.27M |
Less:Impairment of capital assets | ---- | ---- | --0 | -474.57%-41.73M | ---- | ---- | ---- | --0 | -106.03%-7.26M | ---- |
Less:Other special charges | 25.38%-97K | -512.81%-1.24M | ---143K | 57.78%-5.35M | -198.57%-5.02M | 98.23%-130K | -554.84%-203K | ---- | -446.14%-12.68M | ---1.68M |
Less:Write off | --0 | --0 | ---- | -558.89%-1.24M | -73.88%438K | --0 | -19.19%-1.68M | ---- | -97.71%270K | -85.79%1.68M |
Less:Negative goodwill immediately recognized | ---- | ---- | --0 | --6.02M | ---- | ---- | ---- | --0 | --0 | ---- |
Other non-operating income (expenses) | -386.71%-769K | 431.82%584K | -116.37%-82K | 95.94%-46K | -191.03%-213K | 65.73%-158K | 85.81%-176K | 50.00%501K | -135.26%-1.13M | 107.78%234K |
Income before tax | 86.34%222.27M | 100.18%194.93M | 334.07%44.86M | 71.84%337.36M | 360.51%139.87M | 35.21%119.28M | 64.67%97.38M | -203.05%-19.16M | 147.92%196.32M | 108.13%30.37M |
Income tax | 72.09%59.57M | 71.98%50.82M | 6,831.05%14.74M | 43.95%102.19M | 267.43%38.24M | 11.03%34.62M | 51.65%29.55M | -102.21%-219K | 173.17%70.99M | 21.36%10.41M |
Net income | 92.17%162.7M | 112.46%144.11M | 258.97%30.12M | 87.64%235.18M | 409.03%101.63M | 48.42%84.66M | 71.07%67.83M | -318.26%-18.95M | 128.77%125.34M | 105.22%19.97M |
Net income continuous operations | 92.17%162.7M | 112.46%144.11M | 258.97%30.12M | 87.64%235.18M | 409.03%101.63M | 48.42%84.66M | 71.07%67.83M | -318.26%-18.95M | 128.77%125.34M | 105.22%19.97M |
Noncontrolling interests | 235.23%27.76M | 303.60%12.68M | 173.67%2.21M | 291.82%16.2M | 4.45%7.78M | 99.90%8.28M | 232.42%3.14M | 40.97%-3M | 103.47%4.13M | 107.75%7.45M |
Net income attributable to the company | 76.66%134.94M | 103.18%131.44M | 275.01%27.91M | 80.67%218.98M | 649.67%93.85M | 44.39%76.38M | 53.94%64.69M | -215.86%-15.95M | 138.28%121.2M | 104.38%12.52M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 76.66%134.94M | 103.18%131.44M | 275.01%27.91M | 80.67%218.98M | 649.67%93.85M | 44.39%76.38M | 53.94%64.69M | -215.86%-15.95M | 138.28%121.2M | 104.38%12.52M |
Gross dividend payment | ||||||||||
Basic earnings per share | 76.67%0.1166 | 103.04%0.1135 | 274.64%0.0241 | 80.61%0.1891 | 650.00%0.081 | 44.42%0.066 | 53.99%0.0559 | -215.97%-0.0138 | 137.65%0.1047 | 104.30%0.0108 |
Diluted earnings per share | 76.67%0.1166 | 103.04%0.1135 | 274.64%0.0241 | 80.61%0.1891 | 650.00%0.081 | 44.42%0.066 | 53.99%0.0559 | -215.97%-0.0138 | 137.65%0.1047 | 104.30%0.0108 |
Dividend per share | 0.03 | 0 | 100.00%0.03 | 100.00%0.03 | 0.00%0.015 | 0 | 0 | 0.015 | 0.00%0.015 | 0.00%0.015 |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.